Las células madre cardiovasculares avanzan en EE.UU luego de Argentina


Veamos este informe que nos llegó de la mano del doctor Roberto Fernández Viñas que es un pionero mundial en el uso de células madre en el Páncreas para pacientes con diabetes y en otros territorios.

En Sudamérica, desde Argentina, son también pioneros mundiales los doctores argentinos Luis De la Fuente con la inedita técnica mundial transendocárdica junto a Simon Stertzer -ambos de Stanford y el argentino también del Instituto del Diagnóstico y la Clínica SuizoArgentina- para aquellos pacientes con infartos cardíacos crónicos extensos

y, Jorge Trainini para pacientes con miocardiopatías -enfermedades que afectan al músculo cardíaco- debido al Mal de Chagas, desde el Hospital Eva Perón de Avellaneda.

también el cardiocirujano Federico Benetti junto a Fernández Viñas -médico formado en el mítico Sanatorio Guemes- han hecho aportes desde Rosario y otros países de Sudamérica

pasen, y vean...
Standard cardiology patients die at 5 times the rate of cardiology patients treated with stem cells.

We can’t put it any more simply than that. Five times the rate of death. If you or a loved one has a cardiological condition such as cardiomyopathy, angina, or congestive heart failure, are you willing to accept those odds for living vs. dying? Especially when you absolutely don’t have to?

You are probably already very aware – perhaps even painfully aware – that the number one killer in the United States is Heart Disease. And specifically, the most common form of heart disease is coronary artery disease resulting in a reduced flow of blood caused by arterial blockages. The result of long-standing reduced blood flow to the heart muscle is Congestive Heart Failure (CHF).  These two always result in damage to the heart muscle, meaning complete loss of function in portions of the heart. Ultimately, if these are untreated – or, more specifically, mis-treated, as with most so-called standard cardiology – the result is ultimately complete heart failure, better known as “death.”

Can we avoid death from heart diseases? Of course not, but our purpose at Heart Stem Cells ( is to educate you about, and help you to obtain, treatments which can substantially improve the quality of, and prolong the length of, your life.

Take a few moments now and look again at the stick figures at the top of this section. If you have heart disease, which of the figures would you and your loved ones prefer to be? Our guess is the one of the right.

The good news is you can be the figure on the right. An enormous number of studies (many of which you can find on this website or at have proven beyond a shadow of a doubt that treatment for cardiological diseases with autologous stem cells (that is, the patient’s own stem cells) injected directly into the hearts of patients with chronic heart failure improves ventricular performance, quality of life, and survival rate.

Unfortunately, we cannot tell you that stem cell treatments will cure heart diseases (at least not at this point in history), but compared with standard Western cardiology methodology, it will better and prolong your life. We urge you to read the various clinical studies, peer-reviewed scientific papers and personal testimonials (there’s even an article by Barbra Streisand in which she discusses the epidemic of women’s heart disease) on and www.repairstemcells.organd draw your own conclusions. (We’re pretty sure what they’ll be.)

Consider just a few of these ideas, and then if you or a loved one now suffers from heart disease, or you’re worried about the statistically unfortunate probability in the future that you will, read more or contact us directly and we’ll help.

  • In 2002, Western cardiology methodology was able to keep alive for five years 12% of patients waiting for heart transplants. In contrast, Adult/Repair Stem Cell (ASC/RSC) treatments that same year kept 63% of waiting patients alive. That is, 5 times the number of patients treated with stem cells stayed alive, with improved quality of life, than those receiving standard treatments. In fact, about half of those 63% opted out of the transplant list completely and went about their more normal lives!
  • In 2010, Dr. Bodo-EckehardStrauer, MD, of the Heinrich Heine University of Dusseldorf, Germany presented a paper of his findings at the European Society of Cardiology Conference entitled “Stem Cell Transplantation Improves Heart Function and Survival in Chronic Heart Failure.” The paper was the result the longest (5 years) heart stem cell clinical trial in medical history. Dr. Strauer’s conclusion was that “This therapy has almost no risk. It can only be beneficial to patients.  . . . it has real clinical importance for the treatment of heart failure.” And, the statistics? The annual mortality rate for the stem cell group was 7.5 per thousand, while the control group [i.e., those receiving standard treatment] lost 36.8 per thousand. You don’t even need your calculator to see that standard cardiology patients died at 5 times the rate of cardiology patients treated with stem cells.

We know how shocking this all seems -- almost unbelievable, some might say. But the vast numbers of clinical studies, evidence, and personal testimonials are all there. For your convenience, we've compiled just some of the most interesting and impressive articles for you to consider. A list of links follows. And, as always, contact us if you have any additional questions, comments, or testimonials of your own.

First, in case you wish to see abstracts and results of several clinical trials which were published before the Strauer paper, visit and read or download to your heart’s content, literally!

But if you wish to prove to yourself that which we have known absolutely for years – that is, exactly why patients receiving standard cardiology treatments die far more quickly than they would in a medical system which cared about patients more than about profits, then dive into Part 2 and be amazed by the specifics.


Note: Every one of these articles was written by North American, British, or Australian MDs or medical professionals.

Let’s Talk About Real Health Care Reform
By Dr. Larry Malerba, DO, DHt

Question:  Why should we fear even real health care reform?
Answer:  Because it would still only provide access to the same flawed and dangerous practices that make medical care the third leading cause of death in the U.S. annually.

The Angioplasty Debacle
By J. A. Mac Dougall, MD

Question:  Why will your cardiologist advise an angioplasty?
Answer:  $40,000 to $75,000 in his or her pocket (depending on your hospital) plus the billionsstent producers rake in each year.

Bypass Madness
By J. A. Mac Dougall, MD

Question:  Why did a well-respected doctor write an open letter to Bill Clinton advising him to avoid heart bypass surgery?
Answer:  So he wouldn’t risk becoming one of the tens of thousands of heart patients who annually suffer brain dysfunction as a result of bypass surgery.

Unexpected drug reactions land thousands of older patients in hospitals every year
Zachary Marcum, of the University of Pittsburgh's Division of Geriatric Medicine
Dr. Lucian Leape, professor in the Department of Health Policy and Management at the Harvard School of Public Health

Question:  The average heart patient is taking 7 different medicines and runs a substantial risk of adverse reactions which will require hospitalization. Is this syndrome avoidable?
Answer:  Yes! Through ensuring the prescriptions are proper, making sure the patient fully understands the medication, and monitoring the patient more thoroughly.

Aspirin as Good as Plavix for Poor Leg Circulation: Study
Health Day News:  Source:  Juan P. Zambrano, M.D., assistant professor, cardiovascular medicine, coronary/endovascular and stem cell therapies, University of Miami Miller School of Medicine; Feb. 21, 2012, Cardiovascular and Cerebrovascular Disease
Question:  Why are most patients with peripheral artery disease prescribed a blood thinner such as Plavix, with its many side effects, when recent studies suggest aspirin is just as effective?
Answer:  Because Big Pharma makes $0 off aspirin sales.

Do You STILL Believe that Cholesterol Causes Heart Disease?
Dr. Dwight Lundell

Question:  Why does a cardiologist with over 25 years experience say “It is not working!”  to prescribing medications to lower cholesterol and a diet that severely restricted fat intake as the only accepted therapy to prevent heart disease?
Answer:  Because he knows that the real culprit is chronic inflammation.

Heart failure patient’s quality of life suffers most when both they and their caregivers are depressed
Misook Chung, PhD, RN, of the University of Kentucky in Lexington.

Question:  Why should healthcare professionals in a heart failure program  focus on both the patient's and the caregiver's well-being, which is not generally done?
Answer:  Because in a recent study of patient-caregiver pairs, a patient's physical and mental quality of life scores were lowest when both the patient and his or her caregiver were depressed.

Cardiologists, Take Big Money To Give You Inferior Treatments
ProPublica's Charles Ornstein

Question:  Why should we be suspicious of even the best cardiologist at the best hospital?
Answer:  Because many cardiologists get more than half of their funding from medical device and pharmaceutical makers and  often don’t tell patients who receive angioplasty and stents about medications that could be used for treatment.

Doctors rush to heart procedure before proven drugs
Dr. William B. Borden, of Cornell University in New York

Question:  Why do fewer than half of Americans with stable heart disease get guideline-recommended medicines before being rushed off for invasive and expensive heart procedures?
Answer:  3 words – “Profits Above All!” (It could be a sampler on the wall of most hospitals!)

A small victory for patients over unethical medical profiteers
Andrew J. Epstein, PhD, of the Philadelphia Veterans Affairs Medical Center

Question:  Is there any good news about standard cardiology practices in the United States?
Answer:  Yes. There was a marked decline in the rate of coronary artery bypass graft (CABG) surgery led the way to a 15% overall decline in coronary revascularization procedures from 2001 to 2008, according to studies verified JAMA (The Journal of the American Medical Association).

How To Sell Even More Drugs To Dying Heart Patients
By Kristina Fiore, Staff Writer, MedPage Today 
Published: January 17, 2011 Reviewed by Zalman S. Agus, MD; Emeritus Professor 
University of Pennsylvania School of Medicine and 
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner

Question:  Are depression and heart failure linked?
Answer:  Who knows? Recent studies suggest a link, but a co-author reported relationships with Merck, Medtronic, Forest, GE Healthcare, Amgen, Medpage, Roche, Actelion, Johnson & Johnson, Novella, and Trevena.

Want To Survive Heart Disease? Try Fruits And Veggies As 300,000 Europeans Just Proved!
By Nancy Walsh, Staff Writer, MedPage Today
Published: January 18, 2011
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco.

Question:  Is it possible to reduce the risk of dying from heart disease?
Answer:  Yes, according to a huge study (313,074 patients from 10 countries) by the European Prospective Investigation into Cancer and Nutrition (EPIC) which showed that even increasing daily fruit and vegetable intake by just one portion (80 gm or 2.82 oz) led to a 4% decrease in risk of death from ischemic heart disease.

LVADs Not as Good as They Appear to be!
Antone J. Tatooles, MD, of Advocate Christ Medical Center in Oak Lawn, Ill
Dipesh Shah, MD, of Mayo Clinic

Question:  ARE LVADs (left ventricular assist devices) often used to bridge heart failure patients to transplants, all they’re cracked up to be?
Answer:  Maybe not, according to recent studies at the Mayo Clinic and other places which showed LVADs may be responsible for high incidence of gastrointestinal bleeding.

Mood Drugs
Caleb Alexander, MD, of the University of Chicago, and colleagues

Question:  What’s wrong with the growing use of mood drugs?
Answer:  Sserious side effects, including obesity and diabetes, as well as cardiovascular effects and increased mortality among the elderly with dementia. But, on the bright side they make zillions of dollars for Big Pharma!

Whose Fault Is The High Heart Death Rate In The USA?
The Centers for Disease Control and Prevention

Question:  So, whose fault is it?
Answer:  According to a recent report from the Centers for Disease Control (a) The Patients (perhaps even you) who don’t do enough to control risks and (b) the fragmented healthcare system which doesn’t encourage enough coordination among medical professionals involved in your treatment.

No hay comentarios:

Publicar un comentario

Gracias por comentar en Látidos, periodismo cardiovascular.